1967-1971: Undergraduate Student, Biology, LeMoyne College, Syracuse, NY (B.S.)
1973-1978: Graduate Student, Biochemistry, Syracuse University, Syracuse, NY (Ph.D)
1978-1980: Post-doctoral Training Fellow, Clinical Chemistry, Mayo Clinic, Rochester, MN

Academic Appointments

2001-present: Senior Associate Dean for Research and Academic Affairs, University of Vermont College of Medicine, Burlington, VT
2000-2001: Interim Associate Dean for Research, University of Vermont College of Medicine, Burlington, VT
1997-present: Professor (with tenure) of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington, VT
1995-1997: Associate Director of Clinical Chemistry, Fletcher Allen Health Care, Burlington, VT
1993-1997: Associate Professor (with tenure) of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington, VT
1993-1995: Core Laboratory Director, General Clinical Research Center and Sims Obesity and Nutrition Research Center, University of Vermont College of Medicine, Burlington, VT
1988-1993: Assistant Professor (tenure track) of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington, VT
1984-1995: Clinical Chemist, Medical Center Hospital of Vermont, Burlington, VT
1984-1988: Research Assistant Professor of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington,VT
1983-1984: Assistant Professor of Pathology, University of Rochester, Rochester, NY Assistant Director, Clinical Chemistry, Strong Memorial Hospital, Rochester, NY
1980-1983: Postdoctoral Research Fellow, Mayo Clinic, Rochester, MN Consultant, Molecular Anatomy Program, Argonne National Laboratory, Argonne, IL
1978-1980: Postdoctoral Training Fellow in Clinical Chemistry, Mayo Clinic, Rochester, MN

Our laboratory is focused on how various plasma proteins, or factors, which
participate in or regulate a thrombotic event, might contribute to the development of
cardiovascular disease. Our overall hypothesis is that individuals vary in their
propensity to form blood clots much as they vary in their lipid metabolism, and that
this variation is important in determining an individuals risk for cardiovascular
disease. We use a variety of immunoassay and functional assay techniques to probe
plasma samples from large populations in epidemiological studies aimed at
understanding the difference between people in their ability to form blood clots, and
what this difference might mean in terms of cardiovascular risk. We study these
factors in several multicenter projects, including the Cardiovascular Health Study
(older persons over 65 years) and the Strong Heart Study (Native Americans). Our
laboratory is involved in the generation of new assays in this area, with much work
ongoing in the area of the direct measurement of several of these factors. A new area
of interest concerns the relationship between thrombosis and inflammation. We are
probing these systems with tissue culture and animal models to better understand the
molecular events associated with each and the way they inter relate.

Belalcazar, L., Ballantyne, C., Lang, W., Haffner, S., Rushing, J., Schwenke, D., Pi-Sunyer, F., and Tracy, R. Metabolic Factors, Adipose Tissue, and Plasminogen Activator Inhibitor-1 Levels in Type 2 Diabetes: Findings From the Look-AHEAD Study. Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1689-1695.

Shiffman, D., O'Meara, E., Rowland, C., Louie, J., Cushman, M., Tracy, R., Devlin, J., and Psaty, B. The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study. BMC Cardiovasc Disord. 2011 Mar 15;11:10.

Neuhaus, J., Jacobs, D. Jr., Baker, J., Calmy, A., Duprez, D., La Rosa, A., Kuller, L., Pett, S., Ristola, M., Ross, M., Shlipak, M., Tracy, R., and Neaton, J. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010 Jun 15;201(12):1788-95.

Carty, C., Heagerty, P., Heckbert, S., Jarvik, G., Lange, L., Cushman, M., Tracy, R., and Reiner, A. Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study. Ann Hum Genet. 2010 Jan;74(1):1-10.

Schnabel, R., ...31 co-authors..., and Tracy, R. Plenary Paper: Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood. 2010 Jul 1;115(26):5289-99. Epub 2009 Dec 29.

Barasch, E., Gottdiener, J., Aurigemma, G., Kitzman, D., Han, J., Kop, W., and Tracy, R. Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study. Circ Heart Fail. 2009 Jul;2(4):303-10.

All Tracy publications

* indicates equal contribution

Scholar Index (h Index) by Web of Science: 73 (8/2009); by Google Scholar: 78 (8/2009)

Highly cited articles include 2 in the top 50 most cited in "Arteriosclerosis, Thombosis and Vacular Biology" (current Impact Factor 7.2) and 2 in the top 50 most cited in Circulation (current Impact Factor 12.8).

University Distinguished Professor - highest academic award at the University of Vermont (2009)

The Bernie Zak Award for Research – Lipoproteins and Vascular Diseases Division, American Association for Clinical Chemistry (2005)

The Kelly West Lecture – University of Oklahoma Medical Center (2005)

Advisory Board member: Journal of Thrombosis and Haemostasis (2004 - present)

Fellow, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology (2001)

Editorial Board Member: Arteriosclerosis, Thrombosis and Vascular Biology (2000 - present)

Third most cited article in Arteriosclerosis, Thrombosis and Vascular Biology: Tracy R, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Arterioscler. Thromb. Vasc. Biol. 1997;17:1121-1127 (2001)

Distinguished Visiting Professor, Pathology Department, Emory University (2001)

AACC Award for Outstanding Scientific Achievements by a Young Investigator; American Association for Clinical Chemistry and Boehringer Mannheim Diagnostics (1984)

Young Investigator Award - Academy of Clinical Laboratory Physicians and Scientists (1979 and 1982)